Susquehanna International Group, LLP Chembio Diagnostics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 14, 2022	SELL	$1.09 - $2.55 $129,928 - $303,960	-119,200 Reduced 86.56%	18,500 $21,000
Q3 2021 Nov 15, 2021	BUY	$2.06 - $5.34 $233,810 - $606,090	113,500 Added 469.01%	137,700 $344,000
Q1 2021 May 17, 2021	SELL	$3.4 - $7.97 $229,160 - $537,178	-67,400 Reduced 73.58%	24,200 $85,000
Q4 2020 Feb 16, 2021	SELL	$4.11 - $7.51 $293,454 - $536,214	-71,400 Reduced 43.8%	91,600 $435,000
Q3 2020 Nov 16, 2020	SELL	$3.28 - $5.93 $109,224 - $197,469	-33,300 Reduced 16.96%	163,000 $792,000
Q2 2020 Aug 14, 2020	BUY	$3.18 - $15.54 $624,234 - $3.05 Million	196,300 New	196,300 $638,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.